— Company-wide day of service brings more than
700 employees together to volunteer in 25 locations throughout the
U.S., Europe, and Japan —
BRIDGEWATER, N.J., Nov. 2, 2023
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases, today holds its second
annual Global Day of Good, with hundreds of Insmed employees
volunteering simultaneously in their respective communities.
This year's event builds on the success of 2022's inaugural
event, in which more than 500 employees donated over 2,000
volunteer hours to 13 projects supporting 20 organizations around
the world. Today, Insmed will make an even greater impact, with
more than 700 employees volunteering in 25 locations, benefitting
over 20 organizations.
"Insmed's commitment to dedicate a full day of service to
organizations throughout Bridgewater
Township and within Somerset
County, New Jersey, makes for a tremendously positive impact
in our local community," said Bridgewater
Township Mayor, Matthew
Moench. "I'm proud that Insmed's hometown of Bridgewater has been included as part of the
Company's larger global effort to spur meaningful change for
communities around the world."
"At Insmed, our commitment to being a responsible corporate
citizen begins with the patients we serve and extends to all
aspects of our business, including the communities in which we live
and work," said Will Lewis, Chair
and Chief Executive Officer of Insmed. "Today's hands-on activities
exemplify our core values coming to life and reflect the purpose we
live by every day. It is a great source of pride to volunteer
alongside global colleagues as we strive to meet some of the most
pressing needs of our communities."
In line with the Company's approach to supporting its local
communities, each service activity will focus on one of three key
areas of impact: health, education, and human services. Projects
this year include assembling science, technology, engineering, and
mathematics (STEM) kits for students in underserved communities,
preparing and serving meals to people facing food insecurity,
refreshing living spaces for families with children being treated
for serious health conditions, beautifying local schools, and
more.
The Company plans to hold its Global Day of Good annually to
continue its impact on local communities. To learn more about
Insmed's commitment to corporate citizenship, read our 2022
Responsibility Report. To explore opportunities to join our team
and learn why we have been ranked the No. 1 biopharma company to
work for by Science for three years in a row, click
here.
About Insmed
Insmed Incorporated is a global biopharmaceutical company on a
mission to transform the lives of patients with serious and rare
diseases. Insmed's first commercial product is a first-in-disease
therapy approved in the United
States, Europe, and
Japan to treat a chronic,
debilitating lung disease. The Company is progressing a robust
pipeline of investigational therapies targeting areas of serious
unmet need, including neutrophil-mediated inflammatory diseases and
rare pulmonary disorders. Insmed is also advancing an early-stage
research engine encompassing a wide range of technologies and
modalities, including artificial intelligence-driven protein
engineering, gene therapy, and protein manufacturing. Insmed is
headquartered in Bridgewater, New
Jersey, with additional offices and research locations
throughout the United States,
Europe, and Japan. Visit www.insmed.com to learn more.
Contact:
Investors:
Bryan Dunn
Executive Director, Investor Relations
Insmed
(646) 812-4030
bryan.dunn@insmed.com
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Executive Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-holds-second-annual-global-day-of-good-to-benefit-communities-across-the-globe-301974569.html
SOURCE Insmed Incorporated